VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $753,478 | -63.7% | 80,414 | -9.9% | 0.00% | -100.0% |
| Q2 2023 | $2,076,685 | 0.0% | 89,243 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,076,685 | +14.4% | 89,243 | +24.4% | 0.00% | 0.0% |
| Q4 2022 | $1,815,864 | -99.9% | 71,745 | +13.5% | 0.00% | 0.0% |
| Q3 2022 | $1,219,094,000 | -39.1% | 63,231 | -19.5% | 0.00% | 0.0% |
| Q2 2022 | $2,001,076,000 | +15.3% | 78,566 | +16.4% | 0.00% | 0.0% |
| Q1 2022 | $1,735,585,000 | -36.3% | 67,480 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $2,723,309,000 | -1.8% | 65,042 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $2,773,050,000 | -7.2% | 63,719 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $2,986,677,000 | +479.1% | 63,170 | +528.0% | 0.00% | – |
| Q1 2021 | $515,725,000 | +91.4% | 10,059 | 0.0% | 0.00% | – |
| Q4 2020 | $269,380,000 | -93.9% | 10,059 | -92.2% | 0.00% | -100.0% |
| Q3 2020 | $4,403,097,000 | -28.3% | 128,258 | -14.4% | 0.00% | -50.0% |
| Q2 2020 | $6,139,641,000 | – | 149,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |